CDK 4/6 Inhibitors in Metastatic Breast Cancer
1 Visualizações
administrator
07/03/23
Hope S. Rugo, MD, discusses the use of CDK 4/6 inhibitors and their impact on the treatment paradigm for metastatic breast cancer.
Mostre mais
Comentários do Facebook
Nenhum comentário encontrado